Metraipolis › archive › dc_bfda313c3bde

Early Immune Signature Features, Including TLR2 and TLR4 Expression, Are Associated with Complete Remission After CD19 CAR-T Cell Therapy — Europe PMC PMID:42198346

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42198346
DOI: 10.3390/ph19050671
License (as archived): solo-consultazione
Archived: 2026-11-03T06:14:00.838Z
SHA-256 of the archived text: fa6b3d9929359c9c95bdf6331e241308573500c46ff077f5825587f5ddfc59b1
Stable URL of this page: https://metraipolis.com/documento/dc_bfda313c3bde

How to cite

Early Immune Signature Features, Including TLR2 and TLR4 Expression, Are Associated with Complete Remission After CD19 CAR-T Cell Therapy — Europe PMC PMID:42198346 — Europe PMC (en), https://europepmc.org/article/MED/42198346 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bfda313c3bde (Metraipolis archive dc_bfda313c3bde, sha256 fa6b3d9929359c9c95bdf6331e241308573500c46ff077f5825587f5ddfc59b1)

BibTeX

@misc{dcbfda313c3bde,
  title = {Early Immune Signature Features, Including TLR2 and TLR4 Expression, Are Associated with Complete Remission After CD19 CAR-T Cell Therapy — Europe PMC PMID:42198346},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42198346},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bfda313c3bde; sha256 fa6b3d9929359c9c95bdf6331e241308573500c46ff077f5825587f5ddfc59b1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42198346. Agents can read the archived copy with the MCP tool read_document.